Cognition Therapeutics Announces First Patient Dosed in SEQUEL Study of CT1812 Press Release , August 27th, 2020
Cognition Therapeutics Receives $75.8 Million NIA Grant for 540- Patient Phase 2 Study of CT1812 in Collaboration with the Alzheimer’s Clinical Trials Consortium Press Release , June 8th, 2020
Alung Announces Commercial Development of its Breakthrough Next Generation Artificial Lung Press Release , May 5th, 2020
FDA grants Carmell Therapeutics Expedited Review for CT-101, Bone Healing Accelerant Press Release , April 27th, 2020
FDA Grants ALung Emergency Use Authorization (EUA) to the Hemolung ® Respiratory Assist System (RAS) for the Treatment of COVID-19 Press Release , April 24th, 2020
Pittsburgh-based telemedicine company (Wellbridge Health) ramps up offerings Press Release , April 13th, 2020